These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3298407)

  • 41. [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study].
    Hess G; Weber C; Rossol S; Voth R; Drees N; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1988 Jul; 26(7):380-7. PubMed ID: 3223006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural history and therapy of chronic hepatitis B virus infection.
    Alexander GJ; Williams R
    Am J Med; 1988 Aug; 85(2A):143-6. PubMed ID: 3044078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of chronic hepatitis B in children with recombinant alfa interferon. Different response according to age at infection.
    Bruguera M; Amat L; Garcia O; Lambruschini N; Carnicer J; Bergada A; Martin Orte E; Costa J; Sanchez-Tapias JM; Rodés J
    J Clin Gastroenterol; 1993 Dec; 17(4):296-9. PubMed ID: 8308214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of chronic hepatitis B with a combination of acyclovir and human lymphoblastoid interferon.
    Schalm SW
    Chemioterapia; 1988 Dec; 7 Suppl 3():26-9. PubMed ID: 3248317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children.
    Lai CL; Lok AS; Lin HJ; Wu PC; Yeoh EK; Yeung CY
    Lancet; 1987 Oct; 2(8564):877-80. PubMed ID: 2889081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modification of hepatitis B virus infection by recombinant leukocyte alpha A interferon.
    Hess G; Meyer zum Büschenfelde KH
    Immunobiology; 1986 Sep; 172(3-5):255-61. PubMed ID: 3643162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human lymphoblastoid interferon therapy in chronic hepatitis B virus carriers.
    Alexander GJ
    Chemioterapia; 1988 Dec; 7 Suppl 3():9-11. PubMed ID: 3248319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estradiol receptors in the cytosol of peripheral blood mononuclear cells in hepatitis B virus carriers treated with interferon-alpha.
    Mizoguchi Y; Takeda H; Sakagami Y; Seki S; Kobayashi K; Yamamoto S; Morisawa S
    Gastroenterol Jpn; 1989 Aug; 24(4):373-9. PubMed ID: 2777014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alpha-interferon for chronic active hepatitis B in human immunodeficiency virus-infected patients.
    Zylberberg H; Jiang J; Pialoux G; Driss F; Carnot F; Dubois F; Brechot C; Berthelot P; Pol S
    Gastroenterol Clin Biol; 1996; 20(11):968-71. PubMed ID: 9119186
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon in chronic hepatitis B.
    Gregory PB
    Gastroenterology; 1986 Jan; 90(1):237-40. PubMed ID: 3940248
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of chronic type B hepatitis in Southeast Asia.
    Liaw YF; Lin SM; Sheen IS; Chen TJ; Chu CM
    Am J Med; 1988 Aug; 85(2A):147-9. PubMed ID: 3044079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Natural killer cell function during interferon treatment of delta hepatitis.
    Actis GC; Maran E; Saracco G; Rosina F; Baldi M; Brunetto M
    Prog Clin Biol Res; 1987; 234():305-8. PubMed ID: 3628385
    [No Abstract]   [Full Text] [Related]  

  • 53. Lymphoblastoid interferon therapy of chronic HBV infection. A comparison of 12 vs. 24 weeks of thrice weekly treatment.
    Scully LJ; Shein R; Karayiannis P; McDonald JA; Thomas HC
    J Hepatol; 1987 Aug; 5(1):51-8. PubMed ID: 3655310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group.
    Krogsgaard K; Marcellin P; Trepo C; Berthelot P; Sanchez-Tapias JM; Bassendine M; Tran A; Ouzan D; Ring-Larsen H; Lindberg J; Enriquez J; Benhamou JP; Bindslev N
    J Hepatol; 1996 Dec; 25(6):803-13. PubMed ID: 9007706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Core promoter mutations of hepatitis B virus for the response to interferon in e antigen-positive chronic hepatitis B.
    Kanai K; Kako M; Aikawa T; Hino K; Tsubouchi H; Takehira Y; Iwabuchi S; Kawasaki T; Tsuda F; Okamoto H; Miyakawa Y; Mayumi M
    Am J Gastroenterol; 1996 Oct; 91(10):2150-6. PubMed ID: 8855739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interferon alfa-2b therapy in children with chronic hepatitis B.
    Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
    Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
    Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
    Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alpha-interferon therapy for chronic hepatitis B virus infection in children and Oriental patients.
    Lok AS
    J Gastroenterol Hepatol; 1991; 6 Suppl 1():15-7. PubMed ID: 1751798
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates.
    Thomas HC; Scully LJ; Lever AM; Yap I; Pignatelli M
    Infection; 1987; 15 Suppl 1():S26-31. PubMed ID: 2439462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interferon in chronic active hepatitis B. Preliminary results.
    Waked I; Amin M; Abd-el Fattah SA; Osman L; Sabbour M
    Chemioterapia; 1988 Jun; 7(3):198-202. PubMed ID: 3168077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.